My City Builders, Inc. Overview
Industry: Shell Companies
Sector: Financial Services
My City Builders, Inc. operates in the real estate sector. It buys and develops real estate properties for sale or rent to low-income individuals and families. The company was formerly known as iMine Corporation and changed its name to My City Builders, Inc. in April 2023. My City Builders, Inc. is based in Miami, Florida. My City Builders, Inc. operates in the real estate sector. It buys and develops real estate properties for sale or rent to low-income individuals and families. The company was formerly known as iMine Corporation and changed its name to My City Builders, Inc. in April 2023. My City Builders, Inc. is
Research snapshot
This Mavefund research page organizes verified information for My City Builders, Inc. (MYCB), including the company profile, price history, source-linked filings, available financial statements, research signals, and risks to review.
- Listing
- MYCB ยท OTC
- Country
- United States
- Trading currency
- USD
- Industry
- Shell Companies
- Financial coverage
- Annual and interim statements available
Primary sources
Coverage is refreshed automatically and published only after data-integrity validation. Research support only; not personalized financial advice.
Reported Results
No latest earnings report cached yet
The latest source-linked annual or interim company filing has not been cached for this ticker yet.
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported filing facts, organized and linked to the original source.
Verified source-linked statements load when this section enters view.
Source details load with the filing data. Values are standardized company disclosures for research support, not personalized financial advice.